Berlin-based Aignostics, developers of digital pathology solutions, has completed an oversubscribed €14m ($14m) series A financing round.
The round was led by Wellington Partners – who were involved in Quanta Dialysis’ $245m series D round – and...
Minute Insight: Aignostics Completes Raise To Fund AI Pathology Platform
The company has raised €14m to develop its AI-based pathology software which will make diagnosing cancer faster and easier.
More from Minute Insights
More from Medtech Insight
• By
A revised annex to the original decision also outlines expert remuneration limits and introduces further changes.
• By
CMS is proposing to classify all CGMs and insulin pumps as “items requiring frequent and substantial servicing” to expand device choice and access for Medicare beneficiaries. Under this framework, CMS also intends to move Class II devices, which include CGMs from Abbott and Dexcom and pumps from Tan
• By
An upcoming US FDA advisory panel meeting will discuss adding a new indication to allow dermal fillers to be used in the upper chest, or décolletage. Plastic surgeons expect this could drive interest in the procedure, which is already performed off-label.